TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
ALVO

Alvotech

Healthcare · Drug Manufacturers - Specialty & Generic

6.10$ +12.1% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Alvotech (ALVO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,587 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ALVO
Line item Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– – – – 119 119 119 474 251 251 251 598 251 774 683 828 895 911 959 950 1,061 1,068 1,233 1,221 1,245 1,393 1,409 1,487 1,421 1,587
– – – – 22 22 22 86 1.4 1.2 1.1 120 0.6 239 154 231 269 212 228 195 292 285 433 455 459 509 432 574 456 545
– – – – 7.9 7.9 7.9 32 1.1 1.0 0.9 18 0.5 128 13 66 116 60 68 11 65 11 118 51 39 151 43 172 64 143
– – – – 7.9 7.9 7.9 32 1.1 1.0 0.9 18 0.5 128 13 66 116 60 68 11 65 11 118 51 39 151 43 172 64 143
– – – – 9.7 9.7 9.7 33 13 13 13 54 54 38 51 71 46 49 42 87 72 156 146 252 229 180 122 154 107 115
– – – – 2.4 2.4 2.4 9.6 9.8 9.8 9.8 39 39 55 67 71 75 79 82 74 92 97 125 128 142 155 208 220 228 227
– – – – – – – – – – – – 218 218 229 268 – 333 – – – – – – – – – – – –
– – – – 3.4 3.4 3.4 13 3.1 3.1 3.1 12 12 11 11 12 12 12 12 12 12 12 12 11 11 13 13 13 13 12
– – – – 1.6 1.6 1.6 6.3 5.4 5.4 5.4 22 22 23 23 26 15 14 20 19 19 20 21 21 22 55 62 82 120 142
– – – – 335 335 9.7 1,342 23 23 22 734 22 1,071 960 1,393 1,551 1,389 1,620 1,883 1,719 1,674 1,577 1,634 1,548 1,566 1,586 1,772 1,703 1,779
– – – – 13 13 0.9 51 0.8 1.1 3.5 112 6.5 278 202 167 160 222 187 261 247 1,202 161 193 266 280 304 304 260 331
– – – – 0.6 0.6 0.1 8.0 0.1 0.1 0.1 10 0.1 128 83 25 28 30 22 48 49 1,010 34 42 44 60 56 49 56 54
– – – – 3.0 3.0 3.0 12 7.1 7.1 7.1 29 29 45 36 49 30 44 53 81 50 59 58 67 68 84 92 126 98 133
– – – – – – – – – – – 398 – 438 444 745 771 786 898 922 941 57 1,006 1,036 1,064 1,072 1,082 1,262 1,267 1,264
– – – – -217 -217 243 -867 228 228 229 -136 228 -296 -277 -564 -656 -479 -661 -932 -659 -606 -344 -413 -302 -173 -177 -284 -282 -191
– – – – -260 -260 0.0 -1,039 -2.2 -2.4 -21 -1,141 -22 -1,325 -1,334 -1,654 -1,930 -1,741 -1,929 -2,206 -2,425 -2,359 -2,371 -2,438 -2,328 -2,296 -2,301 -2,410 -2,409 -2,476
244 244 244 244 244 244 244 31 31 31 31 31 244 198 198 249 263 228 267 267 267 259 280 302 313 313 300 279 330 357

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?